Chatham Capital Group Inc. Invests $812,000 in Proto Labs, Inc. (PRLB)

Chatham Capital Group Inc. bought a new position in Proto Labs, Inc. (NYSE:PRLB) during the first quarter, according to its most recent filing with the SEC. The firm bought 15,890 shares of the industrial products company’s stock, valued at approximately $812,000. Chatham Capital Group Inc. owned about 0.06% of Proto Labs as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Principal Financial Group Inc. raised its position in shares of Proto Labs by 7.6% in the third quarter. Principal Financial Group Inc. now owns 179,194 shares of the industrial products company’s stock worth $10,736,000 after buying an additional 12,620 shares during the last quarter. Northern Trust Corp raised its position in shares of Proto Labs by 3.5% in the third quarter. Northern Trust Corp now owns 543,135 shares of the industrial products company’s stock worth $32,539,000 after buying an additional 18,181 shares during the last quarter. Suntrust Banks Inc. raised its position in shares of Proto Labs by 12.2% in the third quarter. Suntrust Banks Inc. now owns 5,495 shares of the industrial products company’s stock worth $328,000 after buying an additional 596 shares during the last quarter. American International Group Inc. raised its position in shares of Proto Labs by 0.5% in the third quarter. American International Group Inc. now owns 18,283 shares of the industrial products company’s stock worth $1,095,000 after buying an additional 94 shares during the last quarter. Finally, California State Teachers Retirement System raised its position in shares of Proto Labs by 1.0% in the third quarter. California State Teachers Retirement System now owns 52,228 shares of the industrial products company’s stock worth $3,129,000 after buying an additional 500 shares during the last quarter.

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

Shares of Proto Labs, Inc. (NYSE PRLB) opened at 65.05 on Friday. The company’s 50 day moving average is $63.45 and its 200 day moving average is $55.34. The firm has a market cap of $1.72 billion, a price-to-earnings ratio of 38.95 and a beta of 0.77. Proto Labs, Inc. has a 52-week low of $43.10 and a 52-week high of $68.20.

Proto Labs (NYSE:PRLB) last posted its earnings results on Thursday, April 27th. The industrial products company reported $0.51 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.40 by $0.11. The business had revenue of $80.20 million for the quarter, compared to analyst estimates of $75.05 million. Proto Labs had a net margin of 14.48% and a return on equity of 11.84%. Proto Labs’s revenue was up 10.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.44 EPS. Analysts anticipate that Proto Labs, Inc. will post $2.04 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Chatham Capital Group Inc. Invests $812,000 in Proto Labs, Inc. (PRLB)” was published by Transcript Daily and is owned by of Transcript Daily. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international trademark and copyright law. The original version of this piece of content can be read at https://transcriptdaily.com/2017/06/17/chatham-capital-group-inc-invests-812000-in-proto-labs-inc-prlb-updated-updated.html.

A number of research analysts have issued reports on the stock. TheStreet upgraded shares of Proto Labs from a “c+” rating to a “b-” rating in a research report on Friday, May 5th. Zacks Investment Research upgraded shares of Proto Labs from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a research report on Wednesday, May 3rd. Finally, Dougherty & Co increased their price target on shares of Proto Labs from $42.50 to $45.00 and gave the stock a “sell” rating in a research report on Friday, April 28th.

In related news, Director John B. Tumelty sold 11,896 shares of the company’s stock in a transaction that occurred on Monday, May 8th. The shares were sold at an average price of $61.72, for a total transaction of $734,221.12. Following the sale, the director now owns 4,299 shares of the company’s stock, valued at approximately $265,334.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Rainer Gawlick sold 833 shares of the company’s stock in a transaction that occurred on Monday, May 22nd. The stock was sold at an average price of $64.05, for a total transaction of $53,353.65. Following the sale, the director now directly owns 6,258 shares in the company, valued at approximately $400,824.90. The disclosure for this sale can be found here. Corporate insiders own 7.78% of the company’s stock.

Proto Labs Company Profile

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Receive News & Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply